Moderna aims to seek full FDA approval for COVID-19 vaccine

FILE - In this file photo dated Wednesday, Feb. 17, 2021, three vials of the Moderna COVID-19 Vaccine are pictured in a new coronavirus vaccination center at the 'Velodrom' (velodrome-stadium) in Berlin, Germany. The European Medicines Agency has recommended approving Modernas COVID-19 vaccine for children aged 12 to 17, the first time the shot has been authorized for people under 18. In a decision on Friday, July 23, 2021 the EU drug regulator said research in more than 3,700 children aged 12 to 17 showed that the Moderna vaccine already given the OK for adults across Europe produced a comparable antibody response. (AP Photo/Michael Sohn, File) (Michael Sohn, Copyright 2021 The Associated Press. All rights reserved)

Moderna’s COVID-19 vaccine shows 93% efficacy up to six months after the second dose.

The company says it is now looking for full government approval.

[TRENDING: DeSantis: We are not shutting down | 3,000 Spirit Airlines flights canceled or delayed | Turtle crashes through car windshield]

Moderna is planning to submit its application to the Food and Drug Administration this month.

Right now, the vaccine has emergency use authorization.